Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT01281735
Registration number
NCT01281735
Ethics application status
Date submitted
14/01/2011
Date registered
24/01/2011
Date last updated
17/01/2024
Titles & IDs
Public title
International Chronic Myeloid Leukemia Pediatric Study
Query!
Scientific title
INTERNATIONAL STUDY of Chronic Myeloid Leukaemia (CML) Treatment and Outcomes in Children and Adolescents
Query!
Secondary ID [1]
0
0
2010-023359-27
Query!
Secondary ID [2]
0
0
CIC1402
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
ICMLPed
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Chronic Myeloid Leukemia
0
0
Query!
Condition category
Condition code
Cancer
0
0
0
0
Query!
Leukaemia - Acute leukaemia
Query!
Cancer
0
0
0
0
Query!
Leukaemia - Chronic leukaemia
Query!
Cancer
0
0
0
0
Query!
Children's - Leukaemia & Lymphoma
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Eligibility
Key inclusion criteria
* patients less than 18 years of age
* diagnosed Philadelphia positive and/or BCR-ABL positive Chronic Myeloid Leukemia (CML) all phases
Query!
Minimum age
No limit
Query!
Query!
Maximum age
18
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
* patients more than 18 years of age at diagnosis of CML
Query!
Study design
Purpose
Query!
Duration
Query!
Selection
Query!
Timing
Prospective
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Recruiting
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/01/2011
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
1/12/2028
Query!
Actual
Query!
Sample size
Target
750
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
SA
Query!
Recruitment hospital [1]
0
0
Women's and children's Hospital - North Adelaide
Query!
Recruitment postcode(s) [1]
0
0
5006 - North Adelaide
Query!
Recruitment outside Australia
Country [1]
0
0
Austria
Query!
State/province [1]
0
0
Vienna
Query!
Country [2]
0
0
Belarus
Query!
State/province [2]
0
0
Minsk
Query!
Country [3]
0
0
Belgium
Query!
State/province [3]
0
0
Ghent
Query!
Country [4]
0
0
Brazil
Query!
State/province [4]
0
0
Sao Paulo
Query!
Country [5]
0
0
Chile
Query!
State/province [5]
0
0
Santiago
Query!
Country [6]
0
0
China
Query!
State/province [6]
0
0
Hong Kong
Query!
Country [7]
0
0
Croatia
Query!
State/province [7]
0
0
Zagreb
Query!
Country [8]
0
0
Czechia
Query!
State/province [8]
0
0
Prague
Query!
Country [9]
0
0
Denmark
Query!
State/province [9]
0
0
Copenhagen
Query!
Country [10]
0
0
France
Query!
State/province [10]
0
0
Poitiers
Query!
Country [11]
0
0
Germany
Query!
State/province [11]
0
0
Dresden
Query!
Country [12]
0
0
Greece
Query!
State/province [12]
0
0
Athen
Query!
Country [13]
0
0
Japan
Query!
State/province [13]
0
0
Tokyo
Query!
Country [14]
0
0
Lebanon
Query!
State/province [14]
0
0
Beirut
Query!
Country [15]
0
0
Netherlands
Query!
State/province [15]
0
0
Utrecht
Query!
Country [16]
0
0
Poland
Query!
State/province [16]
0
0
Wroclaw
Query!
Country [17]
0
0
Slovakia
Query!
State/province [17]
0
0
Bratislava
Query!
Country [18]
0
0
Spain
Query!
State/province [18]
0
0
Palma de Mallorca
Query!
Country [19]
0
0
Turkey
Query!
State/province [19]
0
0
Görükle
Query!
Funding & Sponsors
Primary sponsor type
Other
Query!
Name
Poitiers University Hospital
Query!
Address
Query!
Country
Query!
Other collaborator category [1]
0
0
Other
Query!
Name [1]
0
0
CIC Inserm 1402
Query!
Address [1]
0
0
Query!
Country [1]
0
0
Query!
Other collaborator category [2]
0
0
Other
Query!
Name [2]
0
0
University of Milano Bicocca
Query!
Address [2]
0
0
Query!
Country [2]
0
0
Query!
Other collaborator category [3]
0
0
Other
Query!
Name [3]
0
0
University Medical Center Groningen
Query!
Address [3]
0
0
Query!
Country [3]
0
0
Query!
Other collaborator category [4]
0
0
Other
Query!
Name [4]
0
0
University of Liege
Query!
Address [4]
0
0
Query!
Country [4]
0
0
Query!
Other collaborator category [5]
0
0
Other
Query!
Name [5]
0
0
Imperial College London
Query!
Address [5]
0
0
Query!
Country [5]
0
0
Query!
Other collaborator category [6]
0
0
Other
Query!
Name [6]
0
0
University Hospital Dresden
Query!
Address [6]
0
0
Query!
Country [6]
0
0
Query!
Other collaborator category [7]
0
0
Other
Query!
Name [7]
0
0
International BFM Study Group
Query!
Address [7]
0
0
Query!
Country [7]
0
0
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
The purpose of the study is to describe and characterize CML in a large pediatric cohort of patients.
Query!
Trial website
https://clinicaltrials.gov/study/NCT01281735
Query!
Trial related presentations / publications
Meyran D, Petit A, Guilhot J, Suttorp M, Sedlacek P, De Bont E, Li CK, Kalwak K, Lausen B, Culic S, de Moerloose B, Biondi A, Millot F. Lymphoblastic predominance of blastic phase in children with chronic myeloid leukaemia treated with imatinib: A report from the I-CML-Ped Study. Eur J Cancer. 2020 Sep;137:224-234. doi: 10.1016/j.ejca.2020.06.024. Epub 2020 Aug 13. Millot F, Maledon N, Guilhot J, Gunes AM, Kalwak K, Suttorp M. Favourable outcome of de novo advanced phases of childhood chronic myeloid leukaemia. Eur J Cancer. 2019 Jul;115:17-23. doi: 10.1016/j.ejca.2019.03.020. Epub 2019 May 10. Millot F, Guilhot J, Suttorp M, Gunes AM, Sedlacek P, De Bont E, Li CK, Kalwak K, Lausen B, Culic S, Dworzak M, Kaiserova E, De Moerloose B, Roula F, Biondi A, Baruchel A. Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescents. Haematologica. 2017 Oct;102(10):1704-1708. doi: 10.3324/haematol.2017.170035. Epub 2017 Aug 24.
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Frederic MILLOT, MD
Query!
Address
0
0
Poitiers University Hospital
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Frederic MILLOT, MD
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
+33 (0)5 49 44 30 78
Query!
Fax
0
0
Query!
Email
0
0
[email protected]
Query!
Contact person for scientific queries
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results not provided in
https://clinicaltrials.gov/study/NCT01281735
Download to PDF